News Aptar buys digital health partner Healint More evidence of consolidation in the digital health category has come with the news that Aptar has bought Singapore’s Healint, which develops patient support apps as well
R&D Importance of diversity in pharma and clinical trials “Diversity.” It’s a word that is very commonly thrown around right now, not just in pharma and healthcare but across all industries.
R&D Assumptions to evidence: How NIHR project is solidifying UK’... Remote, virtual, or decentralised clinical trials are nothing new, but COVID-19 catapulted the model into the mainstream.
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.